Skip to main content
. 2021 Oct 1;7(6):e183. doi: 10.1192/bjo.2021.1001

Table 4.

Subgroup analyses

Variable Development of mental illness, n (%) Multivariable model, odds ratio (95% CI) P
Male (n = 140 391)
Control 9656/137 977 (7.0) 1
COVID-19 survivors 265/2414 (11.0) 1.67 (1.45–1.92) <0.001
Female (n = 120 492)
Control 9868/116 758 (8.5) 1
COVID-19 survivors 473/3734 (12.7) 2.06 (1.87–2.27) <0.001
Age: 20–39 (n = 109 567)
Control 6948/106 903 (6.5) 1
COVID-19 survivors 213/2664 (8.0) 1.60 (1.36–1.89) <0.001
Age: 40–59 (n = 84 723)
Control 5782/82 600 (7.0) 1
COVID-19 survivors 301/2123 (14.2) 2.27 (1.99–2.58) <0.001
Age: ≥60 (n = 66 593)
Control 6794/65 232 (10.4) 1
COVID-19 survivors 224/1361 (16.5) 1.86 (1.63–2.13) <0.001
Charlson Comorbidity Index: 0–2 (n = 158 863)
Control 11 569/156 343 (7.4) 1
COVID-19 survivors 322/2520 (12.8) 1.93 (1.72–2.15) <0.001
Charlson Comorbidity Index: ≥3 (n = 102 020)
Control 7955/98 392 (8.1) 1
COVID-19 survivors 416/3628 (11.5) 1.93 (1.71–2.17) <0.001

COVID-19, coronavirus disease 2019.